We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XHR
1326
Xenia Hotels & Resorts
XHR
$1.89B
| $3.14M | 0.01% |
148,957
-915
| -0.6% | -$18.3K |
|
|
AMED
1327
DELISTED
Amedisys
AMED
| $3.13M | 0.01% |
55,951
+1,765
| +3% | +$93.3K |
|
|
RDC
1328
DELISTED
Rowan Companies Plc
RDC
| $3.11M | 0.01% |
242,317
-42,995
| -15% | -$461K |
|
|
TGI
1329
DELISTED
Triumph Group
TGI
| $3.11M | 0.01% |
104,649
+2,814
| +3% | +$80.3K |
|
1330
iShares Core S&P Small-Cap ETF
IJR
$110B
| $3.11M | 0.01% |
41,925
+37,625
| +875% | +$2.64M |
|
|
DCH
1331
Dauch Corp
DCH
$1.35B
| $3.09M | 0.01% |
175,796
+3,345
| +2% | +$51.4K |
|
1332
Liberty Broadband Class A
LBRDA
$4.91B
| $3.08M | 0.01% |
32,689
+253
| +0.8% | +$24.1K |
|
|
BOBE
1333
DELISTED
Bob Evans Farms, Inc.
BOBE
| $3.08M | 0.01% |
39,673
+1,230
| +3% | +$84.9K |
|
|
GIMO
1334
DELISTED
Gigamon Inc.
GIMO
| $3.06M | 0.01% |
72,702
+6,815
| +10% | +$278K |
|
|
LEXEA
1335
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $3.06M | 0.01% |
57,665
-116
| -0.2% | -$6.28K |
|
1336
Westlake Corp
WLK
$8.99B
| $3.06M | 0.01% |
36,839
-506
| -1% | -$37.2K |
|
1337
Agios Pharmaceuticals
AGIO
$1.87B
| $3.06M | 0.01% |
45,785
-497
| -1% | -$29.9K |
|
|
WMGI
1338
DELISTED
Wright Medical Group Inc
WMGI
| $3.05M | 0.01% |
117,991
+1,216
| +1% | +$33.5K |
|
|
CXP
1339
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $3.04M | 0.01% |
139,764
-3,181
| -2% | -$68.5K |
|
1340
Prothena Corp
PRTA
$426M
| $3.04M | 0.01% |
46,872
+1,610
| +4% | +$98.6K |
|
1341
First Commonwealth Financial
FCF
$2.16B
| $3.03M | 0.01% |
214,406
+10,423
| +5% | +$134K |
|
|
ENDP
1342
DELISTED
Endo International plc
ENDP
| $3.03M | 0.01% |
353,687
+5,530
| +2% | +$53.3K |
|
|
NVRO
1343
DELISTED
NEVRO CORP.
NVRO
| $3.02M | 0.01% |
33,235
+1,744
| +6% | +$149K |
|
1344
Designer Brands
DBI
$309M
| $3.02M | 0.01% |
140,458
+6,118
| +5% | +$113K |
|
|
ABAX
1345
DELISTED
Abaxis Inc
ABAX
| $3.02M | 0.01% |
67,532
+8,350
| +14% | +$397K |
|
1346
Penumbra
PEN
$12.6B
| $3.01M | 0.01% |
33,351
+344
| +1% | +$29.6K |
|
1347
HUB Group
HUBG
$2.83B
| $3.01M | 0.01% |
139,994
+2,208
| +2% | +$42.1K |
|
1348
Fox Factory Holding Corp
FOXF
$735M
| $3M | 0.01% |
69,639
+3,690
| +6% | +$143K |
|
1349
Rambus
RMBS
$10B
| $3M | 0.01% |
224,517
+2,990
| +1% | +$38.4K |
|
1350
Greif
GEF
$4.93B
| $3M | 0.01% |
51,184
-54
| -0.1% | -$3.08K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.